Exagen Inc
NASDAQ:XGN

Watchlist Manager

Exagen Inc

NASDAQ:XGN

Watchlist

Dividends

Price: 6.98 USD 4.18% Market Closed

Market Cap: 124.9m USD

Have any thoughts about
Exagen Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 6.98 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

XGN Alert

Exagen Inc

6.98

+0.28 (+4.18%)

52 Week Range	1.74 6.98
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Exagen Inc

What unique competitive advantages
does Exagen Inc hold over its rivals?

What risks and challenges
does Exagen Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Exagen Inc.

What unique competitive advantages
does Exagen Inc hold over its rivals?

What risks and challenges
does Exagen Inc face in the near future?

Has there been any significant insider trading activity
in Exagen Inc recently?

Summarize the latest earnings call
of Exagen Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Exagen Inc.

Provide P/S
for Exagen Inc.

Provide P/E
for Exagen Inc.

Provide P/OCF
for Exagen Inc.

Provide P/FCFE
for Exagen Inc.

Provide P/B
for Exagen Inc.

Provide EV/S
for Exagen Inc.

Provide EV/GP
for Exagen Inc.

Provide EV/EBITDA
for Exagen Inc.

Provide EV/EBIT
for Exagen Inc.

Provide EV/OCF
for Exagen Inc.

Provide EV/FCFF
for Exagen Inc.

Provide EV/IC
for Exagen Inc.

Show me price targets
for Exagen Inc made by professional analysts.

What are the Revenue projections
for Exagen Inc?

How accurate were the past Revenue estimates
for Exagen Inc?

What are the Net Income projections
for Exagen Inc?

How accurate were the past Net Income estimates
for Exagen Inc?

What are the EPS projections
for Exagen Inc?

How accurate were the past EPS estimates
for Exagen Inc?

What are the EBIT projections
for Exagen Inc?

How accurate were the past EBIT estimates
for Exagen Inc?

Compare the revenue forecasts
for Exagen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Exagen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Exagen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Exagen Inc compared to its peers.

Compare the P/E ratios
of Exagen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Exagen Inc with its peers.

Analyze the financial leverage
of Exagen Inc compared to its main competitors.

Show all profitability ratios
for Exagen Inc.

Provide ROE
for Exagen Inc.

Provide ROA
for Exagen Inc.

Provide ROIC
for Exagen Inc.

Provide ROCE
for Exagen Inc.

Provide Gross Margin
for Exagen Inc.

Provide Operating Margin
for Exagen Inc.

Provide Net Margin
for Exagen Inc.

Provide FCF Margin
for Exagen Inc.

Show all solvency ratios
for Exagen Inc.

Provide D/E Ratio
for Exagen Inc.

Provide D/A Ratio
for Exagen Inc.

Provide Interest Coverage Ratio
for Exagen Inc.

Provide Altman Z-Score Ratio
for Exagen Inc.

Provide Quick Ratio
for Exagen Inc.

Provide Current Ratio
for Exagen Inc.

Provide Cash Ratio
for Exagen Inc.

What is the historical Revenue growth
over the last 5 years for Exagen Inc?

What is the historical Net Income growth
over the last 5 years for Exagen Inc?

What is the current Free Cash Flow
of Exagen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Exagen Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

XGN Price Targets Summary
Exagen Inc

Wall Street analysts forecast XGN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XGN is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest

Price Target

5.05 USD

28% Downside

Average

Price Target

6.89 USD

1% Downside

Highest

Price Target

8.4 USD

20% Upside

Exagen Inc Competitors:
Price Targets

ALT

Altimmune Inc

297% Upside

IDYA

IDEAYA Biosciences Inc

163% Upside

MDXG

MiMedx Group Inc

87% Upside

VCEL

Vericel Corp

56% Upside

ALT

Altimmune Inc

297% Upside

IDYA

IDEAYA Biosciences Inc

163% Upside

MDXG

MiMedx Group Inc

87% Upside

VCEL

Vericel Corp

56% Upside

IMAB

I-Mab

345% Upside

LXRX

Lexicon Pharmaceuticals Inc

319% Upside

BNTX

BioNTech SE

45% Upside

MDGL

Madrigal Pharmaceuticals Inc

55% Upside

Revenue
Forecast

Revenue Estimate
Exagen Inc

For the last 10 years the compound annual growth rate for Exagen Inc's revenue is 17%. The projected CAGR for the next 3 years is 15%.

17%

Past Growth

15%

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Exagen Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-9%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Exagen Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-13%

Average Miss

What are analyst estimates?

What is XGN's stock price target?

Price Target
6.89 USD

According to Wall Street analysts, the average 1-year price target for XGN is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

What is Exagen Inc's Revenue forecast?

Projected CAGR
15%

For the last 10 years the compound annual growth rate for Exagen Inc's revenue is 17%. The projected CAGR for the next 3 years is 15%.

	Franklin Covey Co NYSE:FC	23.41 USD -1.18%
	Mohawk Industries Inc NYSE:MHK	101.2 USD -0.91%
	Ardmore Shipping Corp NYSE:ASC	9.625 USD 0.26%
	ASGN Inc NYSE:ASGN	52.91 USD 0.09%
	Skyworks Solutions Inc NASDAQ:SWKS	69.31 USD -0.27%
	Weatherford International PLC NASDAQ:WFRD	43.905 USD -3.82%

	Johnson & Johnson NYSE:JNJ	155.3 USD 1.12%
	Bank of America Corp NYSE:BAC	44.175 USD -0.15%
	Mastercard Inc NYSE:MA	582.68 USD 0.85%
	Salesforce Inc NYSE:CRM	263.57 USD -1.26%
	Abbvie Inc NYSE:ABBV	186.155 USD 0.29%
	Home Depot Inc NYSE:HD	368.15 USD -0.04%

	Arista Networks Inc NYSE:ANET	86.16 USD -0.24%
	Visa Inc NYSE:V	365.39 USD 0.83%
	Texas Pacific Land Corp NYSE:TPL	1 119.88 USD -6.55%
	KLA Corp NASDAQ:KLAC	755.52 USD -2.38%
	Manhattan Associates Inc NASDAQ:MANH	189.85 USD 0.51%
	Monolithic Power Systems Inc NASDAQ:MPWR	662.485 USD -2.68%

	Accenture PLC NYSE:ACN	316.25 USD -0.47%
	ServiceNow Inc NYSE:NOW	1 014.8225 USD -0.04%
	Spotify Technology SA NYSE:SPOT	657.4 USD 3.26%
	Monster Beverage Corp NASDAQ:MNST	63.8915 USD 0.4%
	Applied Materials Inc NASDAQ:AMAT	156.88 USD -1.63%
	Synopsys Inc NASDAQ:SNPS	463.89 USD 1.96%

Exagen Inc
NASDAQ:XGN